- Home
- LQDT vs ELVN Comparison
LQDT vs ELVN Comparison
Compare LQDT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- ELVN
- Stock Information
- Founded
- LQDT 1999
- ELVN 2016
- Country
- LQDT United States
- ELVN United States
- Employees
- LQDT N/A
- ELVN N/A
- Industry
- LQDT Catalog/Specialty Distribution
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- LQDT Consumer Discretionary
- ELVN Health Care
- Exchange
- LQDT Nasdaq
- ELVN Nasdaq
- Market Cap
- LQDT 773.6M
- ELVN 927.8M
- IPO Year
- LQDT 2006
- ELVN 2020
- Fundamental
- Price
- LQDT $23.81
- ELVN $19.89
- Analyst Decision
- LQDT Strong Buy
- ELVN Strong Buy
- Analyst Count
- LQDT 2
- ELVN 5
- Target Price
- LQDT $38.50
- ELVN $39.60
- AVG Volume (30 Days)
- LQDT 271.5K
- ELVN 716.7K
- Earning Date
- LQDT 08-07-2025
- ELVN 08-12-2025
- Dividend Yield
- LQDT N/A
- ELVN N/A
- EPS Growth
- LQDT 23.09
- ELVN N/A
- EPS
- LQDT 0.79
- ELVN N/A
- Revenue
- LQDT $439,246,000.00
- ELVN N/A
- Revenue This Year
- LQDT $35.02
- ELVN N/A
- Revenue Next Year
- LQDT $9.90
- ELVN N/A
- P/E Ratio
- LQDT $29.72
- ELVN N/A
- Revenue Growth
- LQDT 35.78
- ELVN N/A
- 52 Week Low
- LQDT $19.31
- ELVN $13.30
- 52 Week High
- LQDT $39.72
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- LQDT 39.20
- ELVN 47.36
- Support Level
- LQDT $23.25
- ELVN $20.22
- Resistance Level
- LQDT $24.09
- ELVN $21.90
- Average True Range (ATR)
- LQDT 0.65
- ELVN 1.51
- MACD
- LQDT 0.15
- ELVN -0.23
- Stochastic Oscillator
- LQDT 33.64
- ELVN 22.58
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.